Christina Kathleen Ullrich, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 21 | 2024 | 3600 | 2.020 |
Why?
|
| Fatigue | 5 | 2022 | 1551 | 0.960 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2023 | 5670 | 0.940 |
Why?
|
| Terminal Care | 7 | 2020 | 1760 | 0.900 |
Why?
|
| Parents | 5 | 2024 | 3564 | 0.680 |
Why?
|
| Grief | 1 | 2022 | 254 | 0.670 |
Why?
|
| Neoplasms | 14 | 2024 | 22164 | 0.630 |
Why?
|
| Terminally Ill | 2 | 2010 | 240 | 0.600 |
Why?
|
| Critical Illness | 3 | 2014 | 2723 | 0.410 |
Why?
|
| Quality of Life | 11 | 2023 | 13361 | 0.380 |
Why?
|
| Stress, Psychological | 7 | 2024 | 4477 | 0.380 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 1590 | 0.350 |
Why?
|
| Chronic Disease | 2 | 2023 | 9320 | 0.330 |
Why?
|
| Reticulocytes | 2 | 2008 | 289 | 0.310 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2775 | 0.300 |
Why?
|
| Self Report | 2 | 2018 | 3724 | 0.290 |
Why?
|
| Nurses | 1 | 2017 | 2478 | 0.290 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2008 | 369 | 0.240 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5146 | 0.240 |
Why?
|
| Research | 1 | 2013 | 1977 | 0.230 |
Why?
|
| Child | 19 | 2024 | 80162 | 0.220 |
Why?
|
| Dyspnea | 2 | 2010 | 1347 | 0.220 |
Why?
|
| Hemoglobins | 2 | 2008 | 1524 | 0.210 |
Why?
|
| Hospitals, Pediatric | 3 | 2019 | 1862 | 0.200 |
Why?
|
| Patient Care Team | 2 | 2024 | 2523 | 0.200 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1600 | 0.190 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2000 | 92 | 0.180 |
Why?
|
| Pain | 2 | 2015 | 5071 | 0.170 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2019 | 49 | 0.170 |
Why?
|
| Baclofen | 1 | 2019 | 120 | 0.160 |
Why?
|
| Muscle Relaxants, Central | 1 | 2019 | 93 | 0.160 |
Why?
|
| Child, Preschool | 9 | 2019 | 42254 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2003 | 597 | 0.160 |
Why?
|
| Hydromorphone | 1 | 2019 | 70 | 0.160 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2019 | 116 | 0.150 |
Why?
|
| Humans | 37 | 2024 | 761423 | 0.140 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 1997 | 72 | 0.140 |
Why?
|
| Family | 3 | 2020 | 3197 | 0.140 |
Why?
|
| Erythrocyte Indices | 2 | 2008 | 144 | 0.130 |
Why?
|
| Communication | 2 | 2022 | 3871 | 0.130 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2000 | 914 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1997 | 430 | 0.120 |
Why?
|
| Leadership | 1 | 2024 | 1385 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 656 | 0.120 |
Why?
|
| Anxiety | 2 | 2024 | 4572 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2015 | 194 | 0.110 |
Why?
|
| Resuscitation Orders | 1 | 2016 | 270 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 12058 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2023 | 3023 | 0.100 |
Why?
|
| Poverty | 1 | 2024 | 2697 | 0.100 |
Why?
|
| Isoenzymes | 1 | 1997 | 1688 | 0.100 |
Why?
|
| Survivors | 1 | 2022 | 2371 | 0.100 |
Why?
|
| Pediatrics | 2 | 2019 | 3595 | 0.100 |
Why?
|
| Caregivers | 2 | 2021 | 2237 | 0.100 |
Why?
|
| Memory | 1 | 2021 | 2187 | 0.100 |
Why?
|
| Child Abuse | 1 | 2020 | 1075 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 4430 | 0.100 |
Why?
|
| Adolescent | 8 | 2019 | 88313 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1461 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2022 | 3600 | 0.090 |
Why?
|
| Linear Models | 2 | 2017 | 5869 | 0.090 |
Why?
|
| Decision Making | 2 | 2016 | 3929 | 0.080 |
Why?
|
| Internet | 1 | 2021 | 3092 | 0.080 |
Why?
|
| Male | 15 | 2024 | 360736 | 0.080 |
Why?
|
| Female | 16 | 2024 | 392581 | 0.080 |
Why?
|
| Caspases | 2 | 2001 | 879 | 0.070 |
Why?
|
| Apoptosis | 2 | 2001 | 9488 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2321 | 0.070 |
Why?
|
| Nausea | 1 | 2010 | 679 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2017 | 54415 | 0.070 |
Why?
|
| Attitude to Death | 1 | 2010 | 400 | 0.070 |
Why?
|
| Dementia | 1 | 2021 | 2686 | 0.070 |
Why?
|
| Prevalence | 2 | 2024 | 15717 | 0.060 |
Why?
|
| Psychometrics | 1 | 2015 | 3065 | 0.060 |
Why?
|
| Psychology | 1 | 2007 | 356 | 0.060 |
Why?
|
| Endocrine System Diseases | 1 | 2007 | 249 | 0.060 |
Why?
|
| Depression | 1 | 2024 | 8122 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4330 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26112 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 13502 | 0.060 |
Why?
|
| Muscular Diseases | 1 | 2007 | 553 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2003 | 5879 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3804 | 0.050 |
Why?
|
| Ferritins | 1 | 2005 | 597 | 0.050 |
Why?
|
| Prognosis | 2 | 2016 | 29620 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39117 | 0.050 |
Why?
|
| Books | 1 | 2021 | 22 | 0.050 |
Why?
|
| Gene Products, tat | 1 | 2001 | 111 | 0.050 |
Why?
|
| Infant | 5 | 2020 | 36205 | 0.050 |
Why?
|
| Adult | 5 | 2024 | 221148 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2022 | 64651 | 0.040 |
Why?
|
| Housing | 1 | 2024 | 670 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 80582 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2019 | 158 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 318 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2019 | 157 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2023 | 2116 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2010 | 9645 | 0.040 |
Why?
|
| Anemia | 1 | 2007 | 1508 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2001 | 3597 | 0.040 |
Why?
|
| ROC Curve | 1 | 2005 | 3580 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2014 | 4811 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5335 | 0.030 |
Why?
|
| DNA Probes | 1 | 1997 | 544 | 0.030 |
Why?
|
| Survival Rate | 1 | 2010 | 12720 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2000 | 727 | 0.030 |
Why?
|
| Income | 1 | 2024 | 1876 | 0.030 |
Why?
|
| Health Priorities | 1 | 2018 | 374 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1834 | 0.030 |
Why?
|
| Philadelphia | 1 | 2015 | 266 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 315 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 1008 | 0.030 |
Why?
|
| Boston | 2 | 2019 | 9330 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1997 | 666 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 74167 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 220826 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 299 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2015 | 412 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 12970 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 4591 | 0.020 |
Why?
|
| Language | 1 | 2021 | 1539 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2015 | 694 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2015 | 8633 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26212 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 17644 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2510 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1997 | 1607 | 0.020 |
Why?
|
| Feedback | 1 | 2014 | 791 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14664 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 1974 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 14599 | 0.020 |
Why?
|
| Patient Participation | 1 | 2018 | 1444 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 4638 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2001 | 18964 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 397 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 10203 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 966 | 0.020 |
Why?
|
| HIV-1 | 1 | 2001 | 6860 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5246 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4244 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 119 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10548 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 188 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 426 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2001 | 731 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1936 | 0.010 |
Why?
|
| United States | 2 | 2022 | 72339 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1997 | 49 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1997 | 49 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 13449 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1997 | 262 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 23441 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 532 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58956 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 1187 | 0.010 |
Why?
|
| Catalysis | 1 | 1997 | 774 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5492 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1405 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 10718 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 1997 | 598 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 9031 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1997 | 2192 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4354 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 169235 | 0.000 |
Why?
|
| Cytokines | 1 | 2001 | 7392 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1997 | 8320 | 0.000 |
Why?
|
| Liver | 1 | 1997 | 7532 | 0.000 |
Why?
|
| Rats | 1 | 1997 | 23742 | 0.000 |
Why?
|
| Animals | 1 | 1997 | 168441 | 0.000 |
Why?
|